Luseogliflozin, a sodium-glucose cotransporter 2 inhibitor, preserves renal function irrespective of acute changes in the estimated glomerular filtration rate in Japanese patients with type 2 diabetes
Kentaro Kohagura, Hironori Yamasaki, Hiroki Takano, Yusuke Ohya, Yutaka Seino
Topics & Concepts
Renal functionMedicineType 2 diabetesInternal medicineCotransporterEndocrinologySodiumDiabetes mellitusUrologyDapagliflozinChemistryOrganic chemistryDiabetes Treatment and ManagementPancreatic function and diabetesChronic Kidney Disease and Diabetes